232 related articles for article (PubMed ID: 8063881)
1. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.
Inamura T; Black KL
J Cereb Blood Flow Metab; 1994 Sep; 14(5):862-70. PubMed ID: 8063881
[TBL] [Abstract][Full Text] [Related]
2. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
3. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
4. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
7. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
8. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
9. Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma.
Inamura T; Nomura T; Ikezaki K; Fukui M; Pöllinger G; Black KL
Neurol Res; 1994 Apr; 16(2):125-8. PubMed ID: 7913997
[TBL] [Abstract][Full Text] [Related]
10. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
11. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
[TBL] [Abstract][Full Text] [Related]
12. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
Baba T; Black KL; Ikezaki K; Chen KN; Becker DP
J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
15. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and cyclic GMP attenuate sensitivity of the blood-tumor barrier permeability to bradykinin.
Sugita M; Hunt GE; Liu Y; Black KL
Neurol Res; 1998 Sep; 20(6):559-63. PubMed ID: 9713849
[TBL] [Abstract][Full Text] [Related]
17. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
18. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cytokines delivery and intercellular adhesion molecule 1 (ICAM-1) expression in glioma by intracarotid infusion of bradykinin analog, RMP-7.
Nakano S; Matsukado K; Black KL
Neurol Res; 1997 Oct; 19(5):501-8. PubMed ID: 9329027
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
